Current position:Home >Product >
N-(2-fluorophenyl)-2-(5-methyl-4-oxidanylidene-6-phenyl-3-prop-2-enyl-thieno[2,3-d]pyrimidin-2-yl)sulfanyl-ethanamide
N-(2-fluorophenyl)-2-(5-methyl-4-oxidanylidene-6-phenyl-3-prop-2-enyl-thieno[2,3-d]pyrimidin-2-yl)sulfanyl-ethanamide
|
|
Canonical SMILES:
CC1=C(SC2=C1C(=O)N(C(=N2)SCC(=O)NC3=CC=CC=C3F)CC=C)C4=CC=CC=C4
Isomeric SMILES
CC1=C(SC2=C1C(=O)N(C(=N2)SCC(=O)NC3=CC=CC=C3F)CC=C)C4=CC=CC=C4
InChI
InChI=1S/C24H20FN3O2S2/c1-3-13-28-23(30)20-15(2)21(16-9-5-4-6-10-16)32-22(20)27-24(28)31-14-19(29)26-18-12-8-7-11-17(18)25/h3-12H,1,13-14H2,2H3,(H,26,29)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 3-[(2-fluorophenyl)methyl]-5-[[3-(4-methoxyphenyl)-1,2-oxazol-5-yl]methylsulfanyl]-1,2,4-triazol-4-amine
- N-(cyclohexylcarbamoyl)-2-[4-(methylsulfonylamino)piperidin-1-yl]ethanamide
- 2-[(5-cyclohexyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]-N-[4-(2-oxidanylidenepyrrolidin-1-yl)phenyl]ethanamide
- 2-methylprop-2-enyl 4-methylsulfonyl-3-nitro-benzoate
- 4-[4-(3-fluorophenyl)-5-[[3-(trifluoromethyl)phenyl]methylsulfanyl]-1,2,4-triazol-3-yl]morpholine
- 2-[(2Z)-2-(2-ethoxy-2-oxidanylidene-ethylidene)-4-oxidanylidene-1,3-thiazolidin-3-yl]ethyl 12-oxidanylidene-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazoline-3-carboxylate
- [3-butyl-7-methyl-2,6-bis(oxidanylidene)purin-8-yl]methyl 1-(2-morpholin-4-yl-2-oxidanylidene-ethyl)cyclopentane-1-carboxylate
- N-[[3,5-dimethyl-1-(phenylmethyl)pyrazol-4-yl]methyl]-6-oxidanylidene-1-(2-phenoxyethyl)pyridazine-3-carboxamide
- 5-[[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methylamino]-2-oxidanylidene-5,6,7,8-tetrahydro-1H-quinoline-3-carboxamide
- 2,4-bis(chloranyl)-5-[[2-(3-methylphenoxy)ethanoylamino]carbamoyl]-N-(2-methylpropyl)benzenesulfonamide

